These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20889008)

  • 1. [The human intestinal microbiota].
    Doré J; Corthier G
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S7-15. PubMed ID: 20889008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial flora in inflammatory bowel disease.
    Marteau P
    Dig Dis; 2009; 27 Suppl 1():99-103. PubMed ID: 20203504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The human gut microbiota: Interactions with the host and dysfunctions].
    Lepage P
    Rev Mal Respir; 2017 Dec; 34(10):1085-1090. PubMed ID: 28506730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine.
    Maier E; Anderson RC; Roy NC
    Nutrients; 2014 Dec; 7(1):45-73. PubMed ID: 25545102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evidence for immunomodulatory effects of probiotic bacteria.
    Ruemmele FM; Bier D; Marteau P; Rechkemmer G; Bourdet-Sicard R; Walker WA; Goulet O
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):126-41. PubMed ID: 19179874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal microbiota, diet and health.
    Power SE; O'Toole PW; Stanton C; Ross RP; Fitzgerald GF
    Br J Nutr; 2014 Feb; 111(3):387-402. PubMed ID: 23931069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metagenomics of the intestinal microbiota: potential applications].
    Dusko Ehrlich S;
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S23-8. PubMed ID: 20889001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
    Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
    Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota, host health, and polysaccharides.
    Xu X; Xu P; Ma C; Tang J; Zhang X
    Biotechnol Adv; 2013; 31(2):318-37. PubMed ID: 23280014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonization and impact of disease and other factors on intestinal microbiota.
    Thompson-Chagoyán OC; Maldonado J; Gil A
    Dig Dis Sci; 2007 Sep; 52(9):2069-77. PubMed ID: 17420934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
    Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
    Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Intestinal Microbiota in Inflammatory Bowel Disease.
    Becker C; Neurath MF; Wirtz S
    ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.
    Pickard JM; Zeng MY; Caruso R; Núñez G
    Immunol Rev; 2017 Sep; 279(1):70-89. PubMed ID: 28856738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.